Tyrosine Kinase Inhibitors (TKIs) - Imatinib (Gleevec) - Pharmacology - CML and ALL Medicosis Perfectionalis 4:20 5 years ago 88 372 Скачать Далее
Brian Druker (OHSU) Part 1: Imatinib (Gleevec): A Targeted Cancer Therapy Science Communication Lab 33:54 14 years ago 42 512 Скачать Далее
5-year update of BFORE: bosutinib vs imatinib in CML VJHemOnc – Video Journal of Hematology & HemOnc 2:12 1 year ago 334 Скачать Далее
Comparing Bosutinib Versus Imatinib in Newly Diagnosed CML Targeted Oncology 2:53 7 years ago 1 089 Скачать Далее
Dr. Timothy Hughes Compares Imatinib to Nilotinib in Chronic Myeloid Leukemia OncLive 1:40 11 years ago 1 511 Скачать Далее
Final results of the BFORE trial: bosutinib vs imatinib in CP-CML VJHemOnc – Video Journal of Hematology & HemOnc 1:10 1 year ago 297 Скачать Далее
Novel agents or imatinib for CML in the frontline setting? VJHemOnc – Video Journal of Hematology & HemOnc 1:27 5 years ago 193 Скачать Далее